← All companies

SGMO

Sangamo Therapeutics, Inc.

SGMOQ OTC Biological Products, (No Diagnostic Substances) EDGAR ↗

$0.09

+0.02 +28.57%

Key statistics

from XBRL data in SEC filings

Market cap

$37.3M

Revenue (TTM)

$34.6M

Net income (TTM)

-$123M

EPS (TTM)

$-0.38

P/E ratio

—

Dividend yield

—

Free cash flow

-$97.3M

Cash

$27.6M

Total assets

$60.0M

Gross margin

—

52-week range

$0.03 – $0.77

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Bankruptcy or receivership; Delisting notice or listing-rule failure Jul 20, 2026 8-K Changed accountants; Other events Jul 1, 2026 8-K/A Jun 23, 2026 8-K Entered a material agreement; Bankruptcy or receivership; Took on a direct financial obligation; Exit or disposal costs Jun 23, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release) May 14, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 30, 2026 8-K Delisting notice or listing-rule failure Apr 29, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Results of operations (earnings release) Mar 30, 2026 8-K Entered a material agreement; Unregistered sale of equity Feb 4, 2026 8-K Other events Feb 3, 2026 8-K Results of operations (earnings release); Director or officer change Feb 3, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Delisting notice or listing-rule failure Oct 29, 2025 8-K Director or officer change Sep 30, 2025 8-K Director or officer change Sep 11, 2025 8-K Other events Sep 4, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Other events Jun 24, 2025 8-K Director or officer change; Shareholder vote results Jun 16, 2025 8-K Other events May 13, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Delisting notice or listing-rule failure May 6, 2025 10-K Fiscal year ended 2024-12-31 Mar 17, 2025 8-K Results of operations (earnings release) Mar 17, 2025 8-K Other events Feb 6, 2025 8-K Terminated a material agreement Dec 30, 2024 8-K Regulation FD disclosure; Other events Dec 10, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Regulation FD disclosure Oct 4, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release) Aug 6, 2024 8-K Other events Jul 24, 2024 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Jun 5, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024